NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sustained Therapeutics

Sustained Therapeutics

Private
Vancouver, British ColumbiaHealthcare & Life Scienceshttps://sustainedtherapeutics.com/

Last Round

Accelerator

Oct 1, 2020

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sustained Therapeutics is a pharmaceutical company that develops a patented sustained-release platform designed to deliver approved drugs for unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug delivery platformsustained-release drug deliveryinjectable polymer gelnon-opioid pain managementopioid alternativelong-acting injectablelocal drug deliverydrug reformulationdepot-forming gelclinical-stage biopharma505(b)(2) pathwaychronic pain treatmentpost-operative painurothelial carcinoma treatmenterectile dysfunction treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sustained Therapeutics Comparables

Compare Sustained Therapeutics with similar companies based on industry and business-model similarity.

Sustained Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Sustained Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 1, 2020
AcceleratorJan 1, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

Graeme Boniface

Chief Operating Officer

Executive Team

Howard Glase

Chief Commercial Officer & Member Board Of Directors

Executive Team

Sustained Therapeutics Investors

Notable investors and investment history

Sustained Therapeutics investors
InvestorRounds
Creative Destruction LabAccelerator
The University of British ColumbiaAccelerator
HATCH Venture BuilderAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 220% MoM.

  • Jun 1, 2025

    Monthly visitors grew 440% MoM, from 611 to 3.3K.

View all signals

Sustained Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sustained Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sustained Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver, British Columbia
Employee Range5
Year Founded2020
Last FundingOct 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.